Milford-based laboratory instrument manufacturer Waters Corp. reported an 8-percent jump in sales for the third quarter and a 15-percent rise in net income as the company cited broad-based demand from pharmaceutical companies for its products.
Waters reported sales of $493 million, a jump of nearly $36 million over the same quarter last year. Meanwhile, the company’s net income, $113.5 million, or $1.36 per share, rose substantially from $98 million, or $1.15 a share.
Waters also improved its financial picture for the first nine months of 2014. Through Sept. 27, when the third quarter closed, the company had taken in $1.41 billion in sales, up from $1.34 last year. However, its net income, $280.3 million, trails what the company earned over the first nine months of 2013, when the company profited $308.4 million.
Earlier this year, Waters announced the acquisition of virtually all the assets of Hungarian technology firm MediMass. The value of the deal was not disclosed.
